8-K: Body and Mind Secures $2.3 Million Credit Facility and Amends Convertible Debentures
Debt Financing Announcement
Body and Mind Inc. has entered into a $2.3 million credit facility with Bengal Catalyst Fund, LP, and amended its existing convertible debentures to improve its financial position.
Summary
- Body and Mind Inc. has secured a non-revolving credit facility of up to $2,317,729.20 from Bengal Catalyst Fund, LP.
- The company has drawn down the full amount of the credit facility on October 28, 2024.
- The credit facility has a term of one year for drawdowns and a two-year maturity from the first drawdown.
- The interest rate on the credit facility is 18% per annum, with a 5% original issue discount.
- The company is required to make monthly interest payments and repay the principal upon maturity or from proceeds of key asset sales.
- The company has also amended its existing convertible debentures with Bengal Catalyst Fund and related entities.
- The interest rate on the convertible debentures has been modified to 15% per annum, with half paid in cash and half paid in kind.
- The lenders have waived the requirement of a Form S-1 registration statement for the shares underlying the convertible debentures for 22 months.
- The convertible debentures are now secured, ranking pari passu with the credit facility.
- The company will issue 1,322,281 shares to the sellers of Canopy Monterey Bay as part of a previous transaction.
Sentiment
Score: 4
Explanation: The document indicates a company in need of capital, securing a high-interest loan and amending existing debt. While the company is taking steps to improve its financial position, the terms of the financing suggest a degree of financial distress.
Positives
- The credit facility provides the company with immediate access to $2.3 million in capital.
- The company has the flexibility to prepay the loan without penalty.
- The amendment to the convertible debentures provides a more manageable interest payment structure.
- The waiver of the S-1 registration requirement for 22 months provides flexibility for the company.
- The company expects a $2.5 million contingent payment in early 2025.
Negatives
- The credit facility has a high interest rate of 18% per annum.
- The 5% original issue discount reduces the net proceeds from the loan.
- The company is obligated to repay the loan from key asset sales.
- The company is subject to restrictions on spending over $10,000 without lender approval.
- The company must maintain minimum liquid assets of $250,000 until the end of 2024 and $350,000 thereafter.
Risks
- The company's ability to repay the loan is dependent on future asset sales or cash flow.
- The high interest rate on the credit facility could strain the company's finances.
- The company is subject to restrictions on spending, which could limit its operational flexibility.
- Failure to maintain minimum liquid assets could trigger an event of default.
- The contingent payment of $2.5 million is not guaranteed.
Future Outlook
The company intends to use the funds from the credit facility to support the development of its dispensary projects in Illinois and New Jersey and to rationalize its asset base. The company also anticipates receiving a $2.5 million contingent payment in early 2025.
Management Comments
- Michael Mills, CEO of Body and Mind, stated that the credit facility gives the company flexibility to accomplish its near-term objectives of rationalizing its asset base and protecting shareholder value.
- Michael Mills also mentioned that the funds will support the development of in-process dispensary projects in Illinois and New Jersey.
Industry Context
The cannabis industry is capital-intensive, and companies often rely on debt financing to fund expansion and operations. This credit facility and the amendment to the convertible debentures are typical financial maneuvers for a company in the growth phase of the cannabis industry.
Comparison to Industry Standards
- The 18% interest rate on the credit facility is relatively high, which may reflect the perceived risk associated with the cannabis industry and the company's financial situation.
- Other cannabis companies have secured debt financing at lower interest rates, but these are often larger, more established companies with stronger financials.
- The use of convertible debentures is a common financing method in the cannabis industry, allowing investors to participate in potential upside while providing the company with capital.
- The amendment to the convertible debentures to include a cash and payment-in-kind interest structure is a common method to manage cash flow.
Related Party Transactions
- Bengal and its related entities are a related party of the Company, and their participation in the Credit Facility and the amendment to the Convertible Debentures constitutes a related party transaction.
Stakeholder Impact
- Shareholders may be concerned about the high interest rate and the potential for dilution.
- Employees may be impacted by the company's financial situation and any potential restructuring.
- Customers may be impacted by the company's ability to maintain operations and expand its retail footprint.
- Suppliers and creditors may be impacted by the company's ability to meet its financial obligations.
Next Steps
- The company will use the funds to develop dispensary projects in Illinois and New Jersey.
- The company will make monthly interest payments on the credit facility.
- The company will repay the principal of the credit facility upon maturity or from key asset sales.
- The company will continue to operate under the terms of the amended convertible debentures.
- The company will issue 1,322,281 shares to the sellers of Canopy Monterey Bay.
Key Dates
| Date | Description |
|---|---|
| December 19, 2022 | Original issue date of the convertible debentures. |
| October 24, 2024 | Effective date of the credit facility agreement, security agreement, and amendments to convertible debentures. |
| October 25, 2024 | Date of the news release announcing the debt financing. |
| October 28, 2024 | Date the credit facility was fully funded. |
| October 30, 2024 | Date of the 8-K filing. |
| October 24, 2025 | The date the company can no longer request loans from the lender. |
| December 19, 2027 | Maturity date of the convertible debentures. |
Keywords
credit facility, convertible debentures, debt financing, cannabis, Bengal Catalyst Fund, security agreement, loan, interest rate, original issue discount, liquidity
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.